Xtl Biopharmaceuticals (XTLB) Treasury Shares (2012 - 2014)

Xtl Biopharmaceuticals (XTLB) has reported Treasury Shares for 1 consecutive years, with -$2.1 million the latest figure, recorded in Q4 2014.

• Quarterly Treasury Shares rose 28.22% year-over-year to -$1.5 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was -$1.5 million (up 28.22% YoY) and the FY2014 annual result came in at -$1.5 million, up 28.22% from the prior year.
• Treasury Shares steadied at -$1.5 million in Q4 2014 per XTLB's latest filing, from -$1.5 million in the prior quarter.
• Over the last five years, Treasury Shares for XTLB reached as high as -$2.1 million in Q4 2014 and fell as low as -$2.1 million in Q4 2014.
• A 3-year average of -$2.0 million and a median of -$2.1 million in 2013 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2013 — Treasury Shares plunged 32.6% — and 2014, when it surged 39.21%.
• Year by year, Treasury Shares stood at -$2.5 million in 2012, then climbed by 15.31% to -$2.1 million in 2013, then increased by 28.22% to -$1.5 million in 2014.
• According to Business Quant data, Treasury Shares over the past three periods registered -$1.5 million, -$1.5 million, and -$1.5 million for Q4 2014, Q3 2014, and Q2 2014 respectively.